Huang Jane bought PRLD
July 4, 2025 · Form 4 insider transaction
Huang Jane bought 9,375 shares of Prelude Therapeutics Incorporated, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,375
Price
N/A
Total value
N/A
InsiderHuang Jane
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 4, 2025
Filing dateJuly 8, 2025
Shares owned after84,252
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock.